Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation

Thromboembolism is the leading cause of cardiovascular mortality. Currently, for the lack of targeting, short half-life, low bioavailability and high bleeding risk of the classical thrombolytic drugs, pharmacological thrombolysis is usually a slow process based on micro-pumping. In addition, frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shichen, Sun, Yao, Zhang, Teng, Cao, Longtao, Zhong, Zhiwei, Cheng, Haoxin, Wang, Qingqing, Qiu, Zhuang, Zhou, Weimin, Wang, Xiaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961464/
https://www.ncbi.nlm.nih.gov/pubmed/35387173
http://dx.doi.org/10.1016/j.bioactmat.2022.03.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961464/
https://www.ncbi.nlm.nih.gov/pubmed/35387173
http://dx.doi.org/10.1016/j.bioactmat.2022.03.013

Ejemplares similares